Learn about clinical trials.
Type what you're trying to understand — a term, a question, a phrase from a trial. We'll surface what fits.
Start anywhere.
What a clinical trial really is
Start at the very beginning. What a trial actually is, why they exist, the myths worth letting go of, and what the "phases" mean.
-
What a clinical trial actually is
A clinical trial is a carefully run research study that tests whether a new way to prevent, find, or treat a disease is safe and works well. In cancer, trials are how nearly every treatment in use today was proven — and taking part can be a way to receive tomorrow's care today, under especially close medical supervision.
-
Why clinical trials exist — and how they help you
Clinical trials exist to answer one question honestly: does a new medical idea actually help people? Nearly every cancer treatment used today was proven this way. A trial serves science and it can serve you — a supervised path to a promising option, sometimes sooner than it would otherwise be available.
-
The myths worth letting go of
Most fears about clinical trials come from myths, not facts. You are not a guinea pig, trials are not only a last resort, you are almost never given a sugar pill instead of treatment, and strict oversight protects you. Knowing the truth lets you weigh a trial calmly, as one real option among several.
-
What the phases mean (Phase 1, 2, 3, 4)
Clinical trials run in ordered steps called phases. Phase 1 checks safety and dosing, Phase 2 looks at whether a treatment works, Phase 3 compares it against today's standard care, and Phase 4 follows it after approval. A lower number is not worse — each phase simply answers a different question.
Could a trial be right for me?
Who trials are really for, when to start looking (earlier than most people think), and what eligibility and biomarkers actually mean for you.
-
Who are clinical trials for?
Clinical trials are for far more people than most assume. There are trials for many cancer types and stages, and for people who are newly diagnosed, currently in treatment, in remission, or living with advanced disease. A trial is not a last resort, and anyone can ask whether one might fit.
-
When should you look at trials?
The best time to consider a clinical trial is early — right after diagnosis and at every point where a treatment decision comes up. Waiting until standard options are exhausted can close doors, because some trials require that you have not had certain treatments yet. It is never too early to ask.
-
What are eligibility criteria?
Eligibility criteria are the rules that decide who can join a clinical trial. They include reasons to join (inclusion criteria) and reasons that would rule you out (exclusion criteria), and they exist to keep participants safe and the science clear. Criteria vary from trial to trial, so not qualifying for one says nothing about you and does not rule out others.
-
What are biomarkers, and why do they matter?
A biomarker is a feature of your cancer — often a gene change or protein, such as HER2, EGFR, or PD-L1 — that helps doctors understand it and choose treatments. Biomarker or molecular testing reads these features, and the results can open doors to targeted trials designed for your cancer's exact profile. It is worth asking your care team whether you have had this testing.
-
What if I don't know all the details yet?
You do not need to know every detail about your cancer to start exploring clinical trials. I am not sure is a completely valid answer, and the screening process itself is designed to help fill in the gaps and clarify whether a trial fits. Gather what you can, and ask your care team about the rest.
What actually happens in a trial
The whole journey — from screening to follow-up — plus your rights, informed consent, what the visits are like, and how risks and benefits are weighed.
-
What is the step-by-step journey of a clinical trial?
Taking part in a clinical trial follows a clear path: you find a trial that might fit, a quick pre-screening checks the basics, you learn every detail and give informed consent, screening tests confirm you can safely join, and then you enroll. From there you begin the treatment and monitoring period, followed by a stretch of follow-up. You can ask questions and stop at any point.
-
What is informed consent, and can I really leave a trial?
Informed consent is the process where the research team explains a trial to you in full, so you can decide freely whether to join. It is an ongoing conversation, not just a one-time signature, and you can ask anything at any time. Most importantly, you can leave a trial at any point, for any reason, without losing your regular medical care.
-
What does taking part in a clinical trial look like day to day?
Day to day, being in a clinical trial looks a lot like regular cancer care, with some added steps. You visit the clinic for treatment and tests, and you keep receiving at least the standard of care plus whatever the trial is studying. You are watched more closely than usual, and a dedicated research team, led by the principal investigator, looks after you throughout.
-
What are the risks and benefits of joining a clinical trial?
A clinical trial offers possible benefits, such as access to a promising new approach, closer monitoring of your health, and the chance to help future patients. It also carries risks, including side effects, unknowns, and extra time. Neither side is hidden from you. Your safety is watched closely the whole way through, and any side effect that comes up, called an adverse event, is tracked and acted on.
-
What are randomization, blinding, and placebos in a cancer trial?
Randomization means a computer, not your doctor, assigns you by chance to one of a trial's groups, which keeps the comparison fair. Blinding means some people are not told which group they are in, to prevent bias. In cancer trials you are almost never denied standard treatment: a pure placebo alone is uncommon, is usually only used when no standard treatment exists, and is always disclosed to you up front.
Cost, coverage & travel
The fear that stops people first. What a trial usually costs you, what insurance and the law cover, and the programs that help with travel and lodging.
-
What does a clinical trial actually cost?
A clinical trial splits into two kinds of cost. Routine care costs are the doctor visits, scans, and standard treatment you would need with or without the trial, and these are usually billed to your insurance as normal. Research costs are the study drug and study-only tests, and these are usually paid by the trial's sponsor, not by you. So a trial can mean a free study drug, but it is not automatically a free ride.
-
Will my insurance cover a clinical trial?
In general, many health plans, including Medicare, are required to cover the routine care costs of a qualifying clinical trial, the same everyday care you would need anyway. The trial's sponsor usually covers the research costs, like the study drug. The exact details depend on your plan and the specific trial, so the reliable move is to confirm with both your insurer and the study team before you enroll.
-
What about travel, lodging, and time away?
Travel, lodging, and time away from work are real costs of joining a trial, and it is fair to weigh them. But help exists. Some trials reimburse travel or lodging, and nonprofit programs offer support like free stays or gas cards. The single best step is to ask the study coordinator one plain question, what support is available to me, because the help often does not show up unless you ask.
-
Money questions to ask before you join a trial
Before joining a trial, a short list of plain questions clears up almost all of the money picture. Ask what will be billed to your insurance, what the sponsor covers, whether there is help with travel, and who to call if a confusing bill shows up. The study team expects these questions, so asking them is smart and completely normal.
Finding trials without drowning
Where trials actually live, how to read a listing without a medical degree, how to spot a red flag, and how to keep track of the ones you're weighing.
-
Where trials are listed
Most U.S. cancer trials are listed in one big public database called ClinicalTrials.gov, a government registry. The National Cancer Institute runs its own cancer-only search on top of the same information. A matching tool sits alongside these lists and helps sort them down to the trials that could fit you.
-
How to read a trial listing
A trial listing looks dense, but only a few parts matter at first. Check whether it is recruiting, what phase it is, roughly who can join, and where it is offered. If it still looks like a fit, find the contact line and reach out. You do not need to understand every word to take the next step.
-
How trialtree is meant to help
trialtree.health is being built to take the whole forest of clinical trials and filter it down to the few leaves that could fit you, in plain language, without hiding any trial you might qualify for. The matching search is still in development, so today you can join a waitlist. It is meant to complement, never replace, ClinicalTrials.gov and your care team.
-
How to spot a legitimate trial
A real clinical trial has oversight from an ethics board, a registered public listing, and a clear consent process — and it never asks you to pay to receive the experimental treatment. Be wary of anything that charges you for the study drug, promises a guaranteed cure, skips written consent, or has no visible oversight. When something feels off, check the public registry and ask your care team.
-
Keeping track of trials you are weighing
When you are weighing several trials, a simple list keeps the overwhelm away. For each one, jot down its name and ID number, the phase, the location, the contact, your questions, and where things stand. A page in a notebook or a basic spreadsheet is plenty. The goal is to think about one trial at a time instead of all of them at once.
Becoming your own advocate
How to raise trials with your oncologist, get a second opinion, gather your records without the overwhelm, and find people who've walked this path.
-
How to talk to your oncologist about trials
Asking about clinical trials is a normal, welcome question — good doctors expect it and take it as a sign you're engaged in your care. You don't need special words. A simple "Are there any clinical trials I should consider?" is enough to start the conversation.
-
Second opinions and clinical-trial navigators
Getting a second opinion is a normal, expected part of cancer care, and it can uncover trial options a first doctor didn't mention — especially at larger or academic centers. You don't have to search alone either: clinical-trial navigators and patient-advocacy groups exist to help you find and understand your options.
-
Gathering your records for a smoother search
A few key documents make trial screening far easier: your pathology report, your cancer type and stage, any biomarker test results, and a short history of your treatments. Think of it as building one simple folder — not a burden, but a tool that saves you time and repeated questions later.
-
You're not doing this alone
You do not have to face a cancer diagnosis, or a trial decision, on your own. Caregivers, support groups, and cancer organizations are there to share the weight — practically and emotionally. Reaching out is a strength, and trusted places like the National Cancer Institute are a good starting point.
-
You're ready
You've learned what a clinical trial is, whether one might fit, what taking part involves, and how to advocate for yourself. That's real knowledge, and it's enough to start the conversation. This final lesson recaps it all and gives you a short list of questions to bring to your care team.
Look up a term.
- Term
Adverse event
Any unwanted medical problem that happens during a trial, from mild to serious; trials track these closely to keep you safe.
- Term
Arm
One of the treatment groups in a trial; each arm gets a specific approach so the groups can be compared.
- Term
Biomarker
A measurable feature of you or your cancer, like a gene change or protein, that can guide treatment and open doors to targeted trials.
- Term
Blinding
When you and/or the researchers don't know which group you're in, to keep the results unbiased; you're told if a trial is blinded before you join.
- Term
Clinical trial
A research study that carefully tests whether a new medical approach is safe and helps people.
- Term
Control group
The group in a trial that gets the current standard treatment, used as a fair yardstick to compare the new approach against.
- Term
ECOG performance status
A simple 0-to-5 scale doctors use to describe how well you can handle everyday activities.
- Term
Eligibility criteria
The list of who can and cannot join a trial, set for safety and clear results; not qualifying says nothing about you as a person.
- Term
Informed consent
The ongoing process of learning what a trial involves so you can freely decide — and you can leave anytime.
- Term
Institutional Review Board (IRB)
An independent ethics committee that reviews a trial to protect the rights, safety, and well-being of the people in it.
- Term
Metastatic
Describes cancer that has spread from where it started to other parts of the body.
- Term
Open-label
A trial where both you and the researchers know exactly which treatment you're getting.
- Term
Phase (of a trial)
The step a treatment trial is in. Phases run in order (1 → 2 → 3 → 4), and each answers a different question.
- Term
Placebo
An inactive treatment sometimes used for comparison; in cancer trials it rarely replaces your real treatment, and any use is told to you up front.
- Term
Principal investigator (PI)
The lead doctor or researcher in charge of running a trial and looking after the safety of everyone in it.
- Term
Protocol
The detailed written plan for a clinical trial — who can join, exactly what happens, and how results are measured.
- Term
Randomization
Being assigned to one group or another purely by chance, like a coin flip, so the comparison stays fair.
- Term
Remission
A decrease in or disappearance of the signs of cancer in your body.
- Term
Standard of care
The best treatment that experts currently agree on for a given situation — the care you'd normally be offered today.
- Term
Washout period
A short waiting stretch before a trial starts, so an earlier medicine can clear your system first.